<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.2 20190208//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.2?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Enzyme Inhib Med Chem</journal-id><journal-id journal-id-type="iso-abbrev">J Enzyme Inhib Med Chem</journal-id><journal-title-group><journal-title>Journal of Enzyme Inhibition and Medicinal Chemistry</journal-title></journal-title-group><issn pub-type="ppub">1475-6366</issn><issn pub-type="epub">1475-6374</issn><publisher><publisher-name>Taylor &#x00026; Francis</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7655067</article-id><article-id pub-id-type="pmid">33167737</article-id><article-id pub-id-type="doi">10.1080/14756366.2020.1837123</article-id><article-id pub-id-type="publisher-id">1837123</article-id><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" vocab-term="Version of Record" article-version-type="VoR">Version of Record</article-version><article-categories><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Research Paper</subject></subj-group></article-categories><title-group><article-title>Crystal structure-guided design of berberine-based novel chitinase inhibitors</article-title><alt-title alt-title-type="left-running-head">L. Chen et al.</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Lei</given-names></name><xref ref-type="aff" rid="AF0001">a</xref><xref ref-type="aff" rid="AF0002">b</xref><xref ref-type="author-notes" rid="FN0001"/></contrib><contrib contrib-type="author"><name><surname>Zhu</surname><given-names>Ling</given-names></name><xref ref-type="aff" rid="AF0003">c</xref><xref ref-type="author-notes" rid="FN0001"/></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Jinli</given-names></name><xref ref-type="aff" rid="AF0001">a</xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Wei</given-names></name><xref ref-type="aff" rid="AF0002">b</xref></contrib><contrib contrib-type="author"><name><surname>Qian</surname><given-names>Xuhong</given-names></name><xref ref-type="aff" rid="AF0003">c</xref><xref ref-type="corresp" rid="AN0001"/></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Qing</given-names></name><xref ref-type="aff" rid="AF0001">a</xref><xref ref-type="aff" rid="AF0002">b</xref><xref ref-type="aff" rid="AF0004">d</xref><xref ref-type="corresp" rid="AN0002"/></contrib><aff id="AF0001"><label>a</label><institution>School of Bioengineering, Dalian University of Technology</institution>, <city>Dalian</city>, <country>China</country></aff><aff id="AF0002"><label>b</label><institution>State Key Laboratory for Biology of Plant Diseases and Insect Pests, Institute of Plant Protection, Chinese Academy of Agricultural Sciences</institution>, <city>Beijing</city>, <country>China</country></aff><aff id="AF0003"><label>c</label><institution>Shanghai Key Laboratory of Chemical Biology, School of Pharmacy, East China University of Science and Technology</institution>, <city>Shanghai</city>, <country>China</country></aff><aff id="AF0004"><label>d</label><institution>Guangdong Laboratory for Lingnan Modern Agriculture, (Shenzhen Branch), Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences</institution>, <city>Shenzhen</city>, <country>China</country></aff></contrib-group><author-notes><fn id="FN0001"><label>*</label><p>These authors contributed equally to this work.</p></fn><fn id="AUFN2"><p>Supplemental data for this article can be accessed <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/14756366.2020.1837123"><underline>here</underline></ext-link>.</p></fn><corresp id="AN0001"><bold>CONTACT</bold> Xuhong Qian <email>xhqian@ecust.edu.cn</email><institution>Shanghai Key Laboratory of Chemical Biology, School of Pharmacy, East China University of Science and Technology</institution>, <city>Shanghai</city><postal-code>200237</postal-code>, <country>China</country></corresp><corresp id="AN0002">Qing Yang <email>qingyang@dlut.edu.cn</email><institution>School of Bioengineering, Dalian University of Technology</institution>, <city>Dalian</city><postal-code>116024</postal-code>, <country>China</country></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>9</day><month>11</month><year>2020</year></pub-date><pub-date date-type="collection" publication-format="electronic"><year>2020</year></pub-date><volume>35</volume><issue>1</issue><fpage seq="182">1937</fpage><lpage>1943</lpage><permissions><copyright-statement>&#x000a9; 2020 The Author(s). Published by Informa UK Limited, trading as Taylor &#x00026; Francis Group.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>The Author(s)</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="IENZ_35_1837123.pdf"/><abstract><title>Abstract</title><p>Glycoside hydrolase family 18 (GH18) chitinases play an important role in various organisms ranging from bacteria to mammals. Chitinase inhibitors have potential applications as pesticides, fungicides, and anti-asthmatics. Berberine, a plant-derived isoquinoline alkaloid, was previously reported to inhibit against various GH18 chitinases with only moderate <italic>K</italic><sub>i</sub> values ranging between 20 and 70&#x02009;&#x003bc;M. In this report, we present for the first time the berberine-complexed crystal structure of <italic>Sm</italic>ChiB, a model GH18 chitinase from the bacterium <italic>Serratia marcescens</italic>. Based on the berberine-binding mode, a hydrophobic cavity-based optimisation strategy was developed to increase their inhibitory activity. A series of berberine derivatives were designed and synthesised, and their inhibitory activities against GH18 chitinases were evaluated. The compound <bold>4c</bold> showed 80-fold-elevated inhibitory activity against <italic>Sm</italic>ChiB and the human chitinase hAMCase with <italic>K</italic><sub>i</sub> values at the sub-micromolar level. The mechanism of improved inhibitory activities was proposed. This work provides a new strategy for developing novel chitinase inhibitors.</p></abstract><kwd-group kwd-group-type="author"><title>Keywords</title><kwd>Berberine</kwd><kwd>chitinase</kwd><kwd>inhibitor</kwd><kwd>structural optimisation</kwd></kwd-group><counts><fig-count count="3"/><table-count count="2"/><page-count count="7"/><word-count count="5106"/></counts></article-meta></front><body><sec id="S0001" disp-level="1"><label>1.</label><title>Introduction</title><p>Glycoside hydrolase family 18 (GH18) chitinases (EC 3.2.1.14) catalyse the degradation of chitin, a homopolymer of &#x003b2;-(1,4)-linked <italic>N</italic>-acetylglucosamine, which play important roles in various life processes. For instance, the well-studied bacterium <italic>Serratia marcescens</italic> produces several GH18 chitinases to efficiently degrade chitin for nutrition<xref rid="CIT0001" ref-type="bibr"><sup>1&#x02013;4</sup></xref>. Chitinases from parasites causing nematodosis<xref rid="CIT0005" ref-type="bibr"><sup>5</sup></xref> and malaria<xref rid="CIT0006" ref-type="bibr"><sup>6</sup></xref> are important for the development and pathogenesis of these organisms. Insect chitinases are required to digest chitin for growth and development<xref rid="CIT0007" ref-type="bibr"><sup>7</sup></xref><sup>,</sup><xref rid="CIT0008" ref-type="bibr"><sup>8</sup></xref>. Human chitinases have been reported to be associated with asthma<xref rid="CIT0009" ref-type="bibr"><sup>9</sup></xref>, allergic response<xref rid="CIT0010" ref-type="bibr"><sup>10</sup></xref>, and other immunological disorders<xref rid="CIT0011" ref-type="bibr"><sup>11</sup></xref><sup>,</sup><xref rid="CIT0012" ref-type="bibr"><sup>12</sup></xref>. Because of the extensive roles of GH18 chitinases, inhibitors targeting these enzymes have potential applications as therapeutic agents and agrochemicals.</p><p>Over the past century, natural products have served as a source and inspiration for a large fraction of the commercial pharmaceuticals for humans, animals, and crops<xref rid="CIT0013" ref-type="bibr"><sup>13&#x02013;15</sup></xref>. The taxonomic, functional, and chemical diversities of natural products offer inherent advantages for driving pharmaceutical discovery<xref rid="CIT0013" ref-type="bibr"><sup>13</sup></xref>. Many natural products have been reported to inhibit GH18 chitinases, such as allosamidin<xref rid="CIT0016" ref-type="bibr"><sup>16</sup></xref>, argifin<xref rid="CIT0017" ref-type="bibr"><sup>17</sup></xref>, argadin<xref rid="CIT0018" ref-type="bibr"><sup>18</sup></xref>, psammaplin A<xref rid="CIT0019" ref-type="bibr"><sup>19</sup></xref>, styloguanidine<xref rid="CIT0020" ref-type="bibr"><sup>20</sup></xref>, phlegmacin B<sub>1</sub><xref rid="CIT0021" ref-type="bibr"><sup>21</sup></xref>, cyclo-(L-Arg-D-Pro)<xref rid="CIT0022" ref-type="bibr"><sup>22</sup></xref> and methylxanthines derivatives<xref rid="CIT0023" ref-type="bibr"><sup>23</sup></xref>, and some of these compounds have shown practical applications.</p><p>Berberine is a plant derived isoquinoline alkaloid distributed widely in plants of the Berberidaceae, Ranunculaceae, and Papaveraceae families<xref rid="CIT0024" ref-type="bibr"><sup>24</sup></xref><sup>,</sup><xref rid="CIT0025" ref-type="bibr"><sup>25</sup></xref>. It has been used for thousands of years in traditional Chinese and Ayurvedic medicine for antimicrobial and antiprotozoal activities<xref rid="CIT0024" ref-type="bibr"><sup>24</sup></xref><sup>,</sup><xref rid="CIT0025" ref-type="bibr"><sup>25</sup></xref>. Several studies have revealed that berberine shows enormous potential in treating various diseases, including cancer, diabetes, depression, cardiovascular and hypertension<xref rid="CIT0026" ref-type="bibr"><sup>26&#x02013;29</sup></xref>. Moreover, berberine has also been reported to have potential applications in agriculture for its antifungal, insecticidal and herbicidal activities<xref rid="CIT0030" ref-type="bibr"><sup>30&#x02013;32</sup></xref>. Recently, it was reported to be a competitive inhibitor of GH18 chitinases, including those from the human (<italic>Hs</italic>Cht and hAMCase) and insect pest <italic>Ostrinia furnacalis</italic> (<italic>Of</italic>ChtI). Berberine showed moderate inhibitory activity towards <italic>Hs</italic>Cht, hAMCase and <italic>Of</italic>ChtI, with <italic>K</italic><sub>i</sub> values of 19, 65 and 23&#x02009;&#x003bc;M, respectively<xref rid="CIT0033" ref-type="bibr"><sup>33</sup></xref>. The modest inhibitory activity of berberine against chitinases remain unsatisfactory for meeting pharmaceutical needs.</p><p>In this study, we used <italic>Sm</italic>ChiB, a model GH18 chitinase from the bacterium <italic>S. marcescens</italic>, to improve inhibitory activity of berberine. Based on the solved crystal structure of <italic>Sm</italic>ChiB-berberine complex, a variety of berberine analogues with much improved inhibitory activities were designed and synthesised. This work provides a new perspective for exploiting berberine as GH18 chitinase inhibitors.</p></sec><sec id="S0002" disp-level="1"><label>2.</label><title>Materials and methods</title><sec id="S0002-S2001" disp-level="2"><label>2.1.</label><title>Chemicals and instruments</title><p>The uncorrected melting point (mp) was obtained with a B&#x000fc;chi B540 apparatus (B&#x000fc;chi Labortechnik AG, Switzerland). <sup>1</sup>H NMR, <sup>13&#x02009;</sup>C NMR and <sup>19&#x02009;</sup>F NMR were recorded on a Bruker AM-400 (<sup>1</sup>H at 400&#x02009;MHz, <sup>13&#x02009;</sup>C at 100&#x02009;MHz and <sup>19&#x02009;</sup>F NMR at 376&#x02009;MHz) spectrometer at 25&#x02009;&#x000b0;C with samples prepared in dimethylsulphoxide (DMSO) and with tetramethylsilane (TMS) used as the internal standard. High-resolution electrospray ionisation mass spectra (HR-ESI-MS) were collected in an XEVO G2 TOF mass spectrometer (Waters, Milford, MA). The chromatographic columns for protein purification were purchased from GE Life Sciences (Beijing, China). The BCA protein assay kit was purchased from TaKaRa (Dalian, China). The yeast strain <italic>Pichia pastoris</italic> GS115, and the expression vectors pPIC9 and pPIC9K were purchased from Invitrogen (Beijing, China). 4-methylumbelliferyl-<italic>&#x003b2;</italic>-D-<italic>N</italic>,<italic>N'</italic>-diacetylchitobiose (MU-<italic>&#x003b2;</italic>-(GlcNAc)<sub>2</sub>) and berberine were purchased from Sigma (Shanghai, China). All other chemicals of the highest purity were purchased from commercial sources.</p></sec><sec id="S0002-S2002" disp-level="2"><label>2.2.</label><title>General procedure for the synthesis of the compounds</title><p>The synthetic route for compounds is shown in <xref ref-type="scheme" rid="SCH0001">Scheme 1</xref>. For the synthesis of the precursor berberrubine (<bold>2</bold>), a suspension of 1&#x02009;g berberine hydrochloride (<bold>1</bold>) and 25&#x02009;ml dimethylformamide (DMF) were stirred at 100&#x02009;W for 1&#x02009;h, and the solvent was removed under vacuum. The residue was purified by column chromatography (silica gel, DCM:MeOH = 3:1) to obtain the desired product berberrubine (<bold>2</bold>). For the synthesis of the precursor <bold>3c</bold>, a suspension of 141&#x02009;mg (1.0&#x02009;mmol) of 6-fluoronicotinic acid in 1&#x02009;ml of oxalyl chloride was stirred for 30&#x02009;min at room temperature. After evaporation of oxalyl chloride <italic>in vacuo</italic>, compound <bold>3c</bold> was obtained and used for the next reaction without any purification.</p><fig id="SCH0001" orientation="portrait" position="float"><label>Scheme 1.</label><caption><p>Synthetic route for the preparation of compounds <bold>4a</bold>-<bold>4c</bold> and precursors. Reagents and conditions: (i) microwave, DMF, stirred at 100&#x02009;W for 1&#x02009;h; (ii) acetonitrile, pyridine, stirred for 1&#x02013;2&#x02009;h, room temperature; (iii) oxalyl chloride, stirred for 30&#x02009;min, room temperature.</p></caption><graphic content-type="color" xlink:href="IENZ_A_1837123_SCH0001_C"/></fig><p>For the synthesis of the target compounds <bold>4a-4c</bold>, compounds <bold>3a-3c</bold> were added into a magnetically stirred solution of berberrubine (<bold>2</bold>) (0.20&#x02009;mol) with 40&#x02009;ml acetonitrile and 4&#x02009;ml pyridine and stirred for 1&#x02013;2&#x02009;h at room temperature. The reaction was monitored by thin-layer chromatography (TLC). The resulting solid was filtered at room temperature and recrystallised twice from methyl alcohol to give the refined product.</p><p>Preparation of compound <bold>4a</bold>: berberrubine (<bold>2</bold>) was treated with methyl succinyl chloride according to the general procedure to give the desired compound <bold>4a</bold> as a yellow solid, yield 54.3%; mp: 192&#x02009;&#x000b0;C (decomp). <sup>1</sup>H NMR (400&#x02009;MHz, DMSO-d<sub>6</sub>) &#x003b4; 9.97 (s, 1H), 9.06 (s, 1H), 8.28 (d, <italic>J</italic>&#x02009;=&#x02009;9.2&#x02009;Hz, 1H), 8.22 (d, <italic>J</italic>&#x02009;=&#x02009;9.2&#x02009;Hz, 1H), 7.81 (s, 1H), 7.10 (s, 1H), 6.18 (s, 2H), 4.96 (t, <italic>J</italic>&#x02009;=&#x02009;6.0&#x02009;Hz, 2H), 4.03 (s, 3H), 3.68 (s, 3H), 3.21 (t, <italic>J</italic>&#x02009;=&#x02009;6.0&#x02009;Hz, 2H), 3.18 (t, <italic>J</italic>&#x02009;=&#x02009;6.8&#x02009;Hz, 2H), 2.81 (t, <italic>J</italic>&#x02009;=&#x02009;6.8&#x02009;Hz, 2H). <sup>13&#x02009;</sup>C NMR (101&#x02009;MHz, DMSO-d<sub>6</sub>) &#x003b4; 172.20, 169.84, 150.45, 149.97, 147.69, 144.30, 138.12, 133.22, 132.93, 130.81, 126.82, 126.00, 121.06, 120.59, 120.31, 108.41, 105.51, 102.11, 57.24, 55.31, 51.68, 28.61, 28.52, 26.14. HR-ESI-MS calculated for C<sub>24</sub>H<sub>22</sub>NO<sub>7</sub><sup>+</sup> [M &#x02013; Cl] <sup>+</sup>: 436.1396, found: 436.1395.</p><p>Preparation of compound <bold>4&#x02009;b</bold>: berberrubine (<bold>2</bold>) was treated with benzoyl chloride according to the general procedure to give the desired compound <bold>4&#x02009;b</bold> as a yellow solid, yield 75.7%; mp: 214.5&#x02013;216.2&#x02009;&#x000b0;C. <sup>1</sup>H NMR (400&#x02009;MHz, DMSO-d<sub>6</sub>) &#x003b4; 10.02 (s, 1H), 9.13 (s, 1H), 8.35 (d, <italic>J</italic>&#x02009;=&#x02009;9.2&#x02009;Hz, 1H), 8.31&#x02009;&#x02212;&#x02009;8.26 (m, 3H), 7.89&#x02009;&#x02212;&#x02009;7.82 (m, 2H), 7.71 (t, <italic>J</italic>&#x02009;=&#x02009;7.8&#x02009;Hz, 2H), 7.09 (s, 1H), 6.19 (s, 2H), 4.92 (t, <italic>J</italic>&#x02009;=&#x02009;6.2&#x02009;Hz, 2H), 4.03 (s, 3H), 3.20 (t, <italic>J</italic>&#x02009;=&#x02009;6.2&#x02009;Hz, 2H). <sup>13&#x02009;</sup>C NMR (101&#x02009;MHz, DMSO-d<sub>6</sub>) &#x003b4; 163.39, 150.39, 149.96, 147.68, 144.47, 138.12, 134.58, 133.53, 132.96, 130.84, 130.39, 129.08, 127.95, 126.96, 125.85, 121.20, 120.65, 120.32, 108.38, 105.55, 102.11, 57.27, 55.20, 26.12. HR-ESI-MS calculated for C<sub>26</sub>H<sub>20</sub>NO<sub>5</sub><sup>+</sup> [M &#x02013; Cl] <sup>+</sup>: 426.1341, found: 426.1342.</p><p>Preparation of compound <bold>4c</bold>: berberrubine (<bold>2</bold>) was treated with 6-fluoronicotinoyl chloride according to the general procedure to give the desired compound <bold>4c</bold> as a yellow solid, yield 63.7%; mp:216&#x02009;&#x000b0;C (decomp). <sup>1</sup>H NMR (400&#x02009;MHz, DMSO-d<sub>6</sub>) &#x003b4; 10.06 (s, 1H), 9.16 (s, 1H), 9.10 (s, 1H), 8.89&#x02009;&#x02212;&#x02009;8.73 (m, 1H), 8.36 (d, <italic>J</italic>&#x02009;=&#x02009;9.0&#x02009;Hz, 1H), 8.29 (d, <italic>J</italic>&#x02009;=&#x02009;9.0&#x02009;Hz, 1H), 7.84 (s, 1H), 7.56 (d, <italic>J</italic>&#x02009;=&#x02009;8.2&#x02009;Hz, 1H), 7.10 (s, 1H), 6.19 (s, 2H), 4.90 (t, <italic>J</italic>&#x02009;=&#x02009;4.1&#x02009;Hz, 2H), 4.05 (s, 3H), 3.21 (t, <italic>J</italic>&#x02009;=&#x02009;0.5&#x02009;Hz, 2H). <sup>13&#x02009;</sup>C NMR (101&#x02009;MHz, DMSO-d<sub>6</sub>) &#x003b4; 166.30 (d, <italic>J</italic>&#x02009;=&#x02009;244.4&#x02009;Hz), 161.78, 151.38 (d, <italic>J</italic>&#x02009;=&#x02009;17.1&#x02009;Hz), 150.89, 150.53, 148.22, 144.98, 144.85 (d, <italic>J</italic>&#x02009;=&#x02009;9.5&#x02009;Hz), 138.79, 133.49, 133.31, 131.37, 127.79, 126.42, 123.59 (d, <italic>J</italic>&#x02009;=&#x02009;4.4&#x02009;Hz), 121.50, 121.12, 120.80, 111.08 (d, <italic>J</italic>&#x02009;=&#x02009;37.9&#x02009;Hz), 108.91, 106.04, 102.63, 57.85, 55.80, 26.63. <sup>19&#x02009;</sup>F NMR (376&#x02009;MHz, DMSO-d<sub>6</sub>) &#x003b4; &#x02212;60.58 (d, <italic>J</italic>&#x02009;=&#x02009;7.7&#x02009;Hz, 1&#x02009;F). HR-ESI-MS calculated for C<sub>25</sub>H<sub>18</sub>FN<sub>2</sub>O<sub>5</sub><sup>+</sup> [M &#x02013; Cl] <sup>+</sup>: 445.1200, found: 445.1198.</p></sec><sec id="S0002-S2003" disp-level="2"><label>2.3.</label><title>Enzyme preparation</title><p>ChiB from <italic>S. marcescens</italic> was expressed in <italic>Escherichia coli</italic> BL21 (DE3). The other GH18 chitinases including the catalytic domains of <italic>Of</italic>ChtI from <italic>O. furnacalis</italic>, human <italic>Hs</italic>Cht and human hAMCase were expressed in <italic>P. pastoris</italic> GS115. All the proteins were purified by immobilised metal affinity chromatography (IMAC) as described previously<xref rid="CIT0034" ref-type="bibr"><sup>34</sup></xref>. The purities of the target proteins were analysed by SDS-PAGE followed by Coomassie Brilliant Blue R-250 staining.</p></sec><sec id="S0002-S2004" disp-level="2"><label>2.4.</label><title>Inhibitory activity assay</title><p>The activity of GH18 chitinases were determined using MU-(GlcNAc)<sub>2</sub> as a substrate. The reaction mixtures used for determining the inhibitor activity of compounds consisted of 100&#x02009;&#x003bc;L of 20&#x02009;nM enzyme, 4&#x02009;&#x003bc;M MU-(GlcNAc)<sub>2</sub>, 1 or 10&#x02009;&#x003bc;M inhibitors and 2% DMSO in the buffer (20&#x02009;mM sodium phosphate, pH 6.0, for <italic>Sm</italic>ChiB, <italic>Of</italic>ChtI and <italic>Hs</italic>Cht; 20&#x02009;mM sodium citrate, pH 5.2, for hAMCase). The reaction in the absence of compounds was used as a positive control. After incubating at 30&#x02009;&#x000b0;C for 25&#x02009;min, an equal volume of 0.5&#x02009;M sodium carbonate was added to the reaction mixtures to terminate the reaction, and the fluorescence produced by the released MU was quantified using a Varioskan Flash microplate reader (Thermo Fisher Scientific, Waltham, MA), with excitation and emission wavelengths of 360 and 450&#x02009;nm, respectively. Experiments were performed in triplicate. For <italic>K</italic><sub>i</sub> value determination, three substrate concentrations (4, 8, and 12&#x02009;&#x003bc;M for <italic>Sm</italic>ChiB, <italic>Hs</italic>Cht and hAMCase, 1, 2, and 4&#x02009;&#x003bc;M for <italic>Of</italic>ChtI) and varied inhibitor concentrations were used. The <italic>K</italic><sub>i</sub> values and types of inhibition were determined by linear fitting of the data in Dixon plots.</p></sec><sec id="S0002-S2005" disp-level="2"><label>2.5.</label><title>Fluorescence measurements</title><p>Tryptophan fluorescence (295&#x02009;nm excitation) was measured at 25&#x02009;&#x000b0;C from 300 to 400&#x02009;nm with a Varioskan Flash microplate reader using excitation and emission band passes of 5&#x02009;nm. Fluorescence quenching experiments were performed in a 200&#x02009;&#x003bc;L mixture containing 1&#x02009;&#x003bc;M protein in the buffer (20&#x02009;mM sodium phosphate, pH 6.0, for <italic>Sm</italic>ChiB, <italic>Of</italic>ChtI and <italic>Hs</italic>Cht; 20&#x02009;mM sodium citrate, pH 5.2, for hAMCase), and by the successive addition of aliquots of compounds stock solution. Since the crystal structure confirmed that berberine binding to <italic>Sm</italic>ChiB in a 1:1 ratio, the dissociation constant <italic>K</italic><sub>d</sub> were then determined using the modified Stern-Volmer equation<xref rid="CIT0035" ref-type="bibr"><sup>35</sup></xref><sup>,</sup><xref rid="CIT0036" ref-type="bibr"><sup>36</sup></xref>.
<disp-formula id="M0001"><alternatives><graphic xlink:href="IENZ_A_1837123_M0001.jpg" position="float" orientation="portrait"/><mml:math id="d2e710"><mml:mrow><mml:msub><mml:mi>F</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>/</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>F</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>&#x02212;</mml:mo><mml:mi>F</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mi mathvariant="normal">&#x000a0;</mml:mi><mml:mo>=</mml:mo><mml:mi mathvariant="normal">&#x000a0;</mml:mi><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mi mathvariant="normal">a</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>K</mml:mi><mml:mi mathvariant="normal">d</mml:mi></mml:msub><mml:mo>/</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mi mathvariant="normal">a</mml:mi></mml:msub><mml:mo stretchy="true">[</mml:mo><mml:mi>Q</mml:mi><mml:mo stretchy="true">]</mml:mo></mml:mrow></mml:math></alternatives></disp-formula>
Where, <italic>F</italic><sub>0</sub> and <italic>F</italic> are fluorescence intensities in the absence and presence of compounds, <italic>f</italic><sub>a</sub> is the fraction of the accessible fluorescence, [<italic>Q</italic>] is the concentration of the compounds and <italic>K</italic><sub>d</sub> is the dissociation equilibrium constant.</p></sec><sec id="S0002-S2006" disp-level="2"><label>2.6.</label><title>Protein crystallisation and structure determination</title><p>Crystallisation experiments were performed by the hanging drop&#x02013;vapor diffusion method at 4&#x02009;&#x000b0;C. <italic>Sm</italic>ChiB was firstly desalted in the 20&#x02009;mM Tris-HCl with 50&#x02009;mM NaCl, pH 8.0, and concentrated to 10&#x02009;mg/mL before crystallisation. The crystals of free <italic>Sm</italic>ChiB were obtained in 1.0&#x02013;2.0 M ammonium sulphate, 10&#x02013;20% glycerol, 100&#x02009;mM HEPES, pH 7.0 and then soaked with berberine to a final concentration of 1&#x02009;mM for 1&#x02009;h to yield the <italic>Sm</italic>ChiB-berberine complex. The crystals were cryoprotected by immersion in mother liquor containing 25% glycerol and flashed-cooled in liquid nitrogen.</p><p>X-ray diffraction data of the complex were collected at the National Centre for Protein Science, Shanghai (BL18U, Pilatus 3&#x02013;6&#x02009;M detector). The structure of <italic>Sm</italic>ChiB complexed with berberine was solved by molecular replacement with PHASER<xref rid="CIT0037" ref-type="bibr"><sup>37</sup></xref> using the structure of free <italic>Sm</italic>ChiB (PDB: le6n) as the search model. The PHENIX<xref rid="CIT0038" ref-type="bibr"><sup>38</sup></xref> was used for structure refinement. Coot<xref rid="CIT0039" ref-type="bibr"><sup>39</sup></xref> was used for manually building and extending the molecular models. PROCHECK<xref rid="CIT0040" ref-type="bibr"><sup>40</sup></xref> was used to check the stereochemical quality of the models. The coordinates of the <italic>Sm</italic>ChiB-berberine complex were deposited in the Protein Data Bank (PDB) as entries 7C34. All structure figures were generated using PyMOL (DeLano Scientific LLC).</p></sec><sec id="S0002-S2007" disp-level="2"><label>2.7.</label><title>Molecular docking</title><p>The PDB files of berberine and its analogs were prepared using PRODRG<xref rid="CIT0041" ref-type="bibr"><sup>41</sup></xref>. The crystal structures of <italic>Sm</italic>ChiB (PDB: 7C34), <italic>Of</italic>ChtI (PDB: 3WQW), <italic>Hs</italic>Cht (PDB: 1HKK) and hAMCase (PDB: 2YBT) were prepared by PyMOL as the templates for the molecular docking. MGLTools was used to generate the PDBQT files of the proteins and compounds. The active site boxes were set at 50&#x02009;&#x000d7;&#x02009;50&#x02009;&#x000d7;&#x02009;50 &#x000c5;<sup>3</sup>, 70&#x02009;&#x000d7;&#x02009;70&#x02009;&#x000d7;&#x02009;60 &#x000c5;<sup>3</sup>, 70&#x02009;&#x000d7;&#x02009;70&#x02009;&#x000d7;&#x02009;70 &#x000c5;<sup>3</sup> and 60&#x02009;&#x000d7;&#x02009;80&#x02009;&#x000d7;&#x02009;60 &#x000c5;<sup>3</sup> for <italic>Sm</italic>ChiB, <italic>Hs</italic>Cht, <italic>Of</italic>ChtI and hAMCase using AutoGrid4<xref rid="CIT0042" ref-type="bibr"><sup>42</sup></xref>, respectively. Molecular Docking were performed by AutoDock4<xref rid="CIT0042" ref-type="bibr"><sup>42</sup></xref> using the Lamarckian genetic algorithm with a population size of 100 individuals, 25000000 energy evaluations, and 27000 generations. Plausible docking models were selected from the abundant clusters [root-mean-square deviation (RMSD) = 2&#x02009;&#x000c5;] that had the lowest binding energies.</p></sec></sec><sec id="S0003" disp-level="1"><label>3.</label><title>Results and discussion</title><sec id="S0003-S2001" disp-level="2"><label>3.1.</label><title>The binding mode of berberine in SmChiB</title><p>Berberine was reported as a competitive inhibitor towards several GH18 chitinases including <italic>Of</italic>ChtI, <italic>Hs</italic>Cht, and hAMCase<xref rid="CIT0033" ref-type="bibr"><sup>33</sup></xref>. In this study, we found berberine was also a competitive inhibitor against <italic>Sm</italic>ChiB, a well-studied GH18 chitinase, with a <italic>K</italic><sub>i</sub> value of 11.79 &#x003bc;&#x0039c; (<xref rid="t0001" ref-type="table">Table 1</xref>, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/14756366.2020.1837123">Figure S1</ext-link>). To improve inhibitory activity, the binding mode of berberine in the <italic>Sm</italic>ChiB active pocket was analysed. The crystal structure of the <italic>Sm</italic>ChiB-berberine complex was obtained by soaking and was resolved to a resolution of 1.94&#x02009;&#x000c5;. The statistics of data collection and structure refinement are shown in <xref rid="t0002" ref-type="table">Table 2</xref>. The coordinates of the <italic>Sm</italic>ChiB&#x02013;berberine complex have been deposited in the PDB under accession number 7C34.</p><table-wrap id="t0001" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Inhibitory activities and binding affinities of the compounds towards different GH18 chitinases.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/></colgroup><thead><tr><th>&#x000a0;</th><th colspan="8" align="center">&#x003bc;M<hr/></th></tr><tr><th align="left">&#x000a0;</th><th colspan="2" align="center"><italic toggle="yes">Sm</italic>ChiB<hr/></th><th colspan="2" align="center"><italic toggle="yes">Of</italic>ChtI<hr/></th><th colspan="2" align="center"><italic toggle="yes">Hs</italic>Cht<hr/></th><th colspan="2" align="center">hAMCase<hr/></th></tr><tr><th align="left">Compounds</th><th align="center"><italic toggle="yes">K</italic><sub>i</sub></th><th align="center"><italic toggle="yes">K</italic><sub>d</sub></th><th align="center"><italic toggle="yes">K</italic><sub>i</sub></th><th align="center"><italic toggle="yes">K</italic><sub>d</sub></th><th align="center"><italic toggle="yes">K</italic><sub>i</sub></th><th align="center"><italic toggle="yes">K</italic><sub>d</sub></th><th align="center"><italic toggle="yes">K</italic><sub>i</sub></th><th align="center"><italic toggle="yes">K</italic><sub>d</sub></th></tr></thead><tbody valign="top"><tr><td align="left">Berberine</td><td align="char" char=".">11.79</td><td align="char" char=".">11.98</td><td align="center">23<sup>33</sup></td><td align="char" char=".">20.61</td><td align="center">19<sup>33</sup></td><td align="char" char=".">21.89</td><td align="center">65<sup>33</sup></td><td align="char" char=".">58.03</td></tr><tr><td align="left"><bold>4a</bold></td><td align="char" char=".">0.68</td><td align="char" char=".">1.12</td><td align="char" char=".">6.43</td><td align="center">&#x02013;</td><td align="char" char=".">8.23</td><td align="center">&#x02013;</td><td align="char" char=".">7.43</td><td align="center">&#x02013;</td></tr><tr><td align="left"><bold>4b</bold></td><td align="char" char=".">2.36</td><td align="char" char=".">2.99</td><td align="char" char=".">7.28</td><td align="center">&#x02013;</td><td align="char" char=".">11.39</td><td align="center">&#x02013;</td><td align="char" char=".">4.62</td><td align="center">&#x02013;</td></tr><tr><td align="left"><bold>4c</bold></td><td align="char" char=".">0.15</td><td align="char" char=".">0.19</td><td align="char" char=".">3.03</td><td align="char" char=".">2.58</td><td align="char" char=".">0.35</td><td align="char" char=".">0.34</td><td align="char" char=".">0.80</td><td align="char" char=".">1.12</td></tr></tbody></table></table-wrap><table-wrap id="t0002" orientation="portrait" position="float"><label>Table 2.</label><caption><p>Details of data collection and structure refinement.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*"/><col width="1*"/></colgroup><thead><tr><th align="left">&#x000a0;</th><th align="center"><italic toggle="yes">Sm</italic>ChiB-Berberine</th></tr></thead><tbody valign="top"><tr><td align="left">Space group</td><td align="left"><italic toggle="yes">P</italic> 2<sub>1</sub> 2<sub>1</sub> 2<sub>1</sub></td></tr><tr><td align="left">Unit-cell parameters</td><td align="left">&#x000a0;</td></tr><tr><td align="left"><italic toggle="yes">&#x02003;a</italic>, <italic toggle="yes">b</italic>, <italic toggle="yes">c</italic> (&#x000c5;)</td><td align="left">56.09, 103.77, 186.51</td></tr><tr><td align="left"><italic toggle="yes">&#x02003;&#x003b1;</italic>, <italic toggle="yes">&#x003b2;</italic>, <italic toggle="yes">&#x003b3;</italic> (&#x000b0;)</td><td align="left">90, 90, 90</td></tr><tr><td align="left">&#x02003;Wavelength (&#x000c5;)</td><td align="left">0.9778</td></tr><tr><td align="left">&#x02003;Temperature (K)</td><td align="left">100</td></tr><tr><td align="left">&#x02003;Resolution (&#x000c5;)</td><td align="left">29.78-1.94 (2.008-1.94)</td></tr><tr><td align="left">&#x02003;Unique reflections</td><td align="left">81619 (7997)</td></tr><tr><td align="left">&#x02003;Observed reflections</td><td align="left">991829</td></tr><tr><td align="left"><italic toggle="yes">&#x02003;R</italic><sub>merge</sub></td><td align="left">0.05 (0.152)</td></tr><tr><td align="left">&#x02003;Average multiplicity</td><td align="left">7.0 (6.8)</td></tr><tr><td align="left">&#x02003;Mean <italic toggle="yes">I/&#x003c3;I</italic></td><td align="left">8.55 (2.1)</td></tr><tr><td align="left">&#x02003;Completeness (%)</td><td align="left">99.87 (99.27)</td></tr><tr><td align="left">&#x02003;R/R<sub>free</sub></td><td align="left">0.163/0.195</td></tr><tr><td align="left">&#x02003;Protein residues</td><td align="left">992</td></tr><tr><td align="left">&#x02003;Water molecules</td><td align="left">740</td></tr><tr><td align="left">&#x02003;Other atoms</td><td align="left">84</td></tr><tr><td colspan="2">Root mean square deviations</td></tr><tr><td align="left">&#x02003;Bond lengths (&#x000c5;)</td><td align="left">0.012</td></tr><tr><td align="left">&#x02003;Bond angles (&#x000b0;)</td><td align="left">1.38</td></tr><tr><td align="left">&#x02003;Wilson B factor (&#x000c5;<sup>2</sup>)</td><td align="left">27.44</td></tr><tr><td align="left">&#x02003;Average B factor (&#x000c5;<sup>2</sup>)</td><td align="left">32.24</td></tr><tr><td align="left">&#x02003;Protein atoms</td><td align="left">31.30</td></tr><tr><td align="left">&#x02003;Water molecular</td><td align="left">33.40</td></tr><tr><td align="left">&#x02003;Ligand molecules</td><td align="left">80.50</td></tr><tr><td colspan="2">Ramachandran plot (%)</td></tr><tr><td align="left">&#x02003;Most favoured</td><td align="left">98</td></tr><tr><td align="left">&#x02003;Additionally allowed</td><td align="left">2</td></tr><tr><td align="left">&#x02003;Outliers</td><td align="left">0</td></tr><tr><td align="left">PDB code</td><td align="left">7C34</td></tr></tbody></table></table-wrap><p>The crystal complex structure clearly revealed the location of berberine in the active pocket of <italic>Sm</italic>ChiB (<xref ref-type="fig" rid="F0001">Figure 1(B)</xref>). Berberine occupied the active pocket across the sugar-binding subsites +1 and +2 which was characterised by the aromatic Trp<sup>97</sup> and Trp<sup>220</sup>, respectively. The nomenclature for sugar-binding subsites was proposed by Davies et&#x000a0;al<xref rid="CIT0043" ref-type="bibr"><sup>43</sup></xref>, where subsite&#x02009;+&#x02009;n represents the reducing end and subsite &#x02013;n represents the non-reducing end. The conjugate tetracycle plane (<xref ref-type="fig" rid="F0001">Figure 1(A)</xref>) of berberine was sandwiched by Trp<sup>97</sup> and Trp<sup>220</sup> to form &#x003c0;-&#x003c0; stacking interactions within distance of 4.2 and 4.3&#x02009;&#x000c5; respectively. This observation was consistent with our previous work that berberine inhibited GH18 chitinases mainly via &#x003c0;-&#x003c0; stacking interactions between the tetracycle plane and the aromatic residues in the binding pockets<xref rid="CIT0033" ref-type="bibr"><sup>33</sup></xref>. This finding inspired us to retain the conjugate plane of berberine in the next design of berberine-based inhibitors. Moreover, an unoccupied hydrophobic cavity formed by residues Phe<sup>190</sup>, Phe<sup>191</sup>, Leu<sup>216</sup>, Phe<sup>239</sup>, and Leu<sup>265</sup> was identified (<xref ref-type="fig" rid="F0001">Figure 1(B)</xref>). This space provides a favourable opportunity for the optimisation of berberine at its 9-<italic>O</italic>-position or 10-<italic>O</italic>-position. As the 9-<italic>O</italic>-position had been reported to be readily modified<xref rid="CIT0044" ref-type="bibr"><sup>44&#x02013;46</sup></xref>, it might be a candidate site for derivation of berberine for improving inhibitory activity.</p><fig id="F0001" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>Crystal structure of <italic>Sm</italic>ChiB in complex with berberine. (A) Structure of berberine. The conjugate tetracycle plane is shown in green-cyan, the 9-<italic>O</italic>-methoxy and 10-<italic>O</italic>-methoxy moieties are shown in pink. (B) Binding mode of berberine in the active pocket of <italic>Sm</italic>ChiB. Berberine is shown in stick representation with carbon atoms in green. The aromatic residues that stack with berberine are labelled and shown in stick representation with carbon atoms in yellow. The amino residues forming the hydrophobic cavity extended near the +2 subsite are labelled and shown as stick representation with carbon atoms in blue. The numbers indicate the subsite to which the berberine is bound.</p></caption><graphic content-type="color" xlink:href="IENZ_A_1837123_F0001_C"/></fig></sec><sec id="S0003-S2002" disp-level="2"><label>3.2.</label><title>Design, synthesis and biological activity of berberine analogs</title><p>Modification of berberine was performed by substituting a variety of groups at the 9-<italic>O</italic>-position. Three hydrophobic and bulky substituents including a methyl succinyl group, benzoyl group and 6-fluoronicotinoyl group were selected. The addition of a carbonyl group, fluorine atom and nitrogen atom in the substituents were expected to form hydrogen bonds with surrounding residues in the hydrophobic cavity. The compounds <bold>4a</bold>-<bold>4c</bold> were obtained according to the synthetic route outlined in <xref ref-type="scheme" rid="SCH0001">Scheme 1</xref>. Briefly, the key intermediate berberrubine (<bold>2</bold>) was obtained via microwave reaction<xref rid="CIT0047" ref-type="bibr"><sup>47</sup></xref>. Berberrubine was then treated with excess acyl chloride <bold>3a-3c</bold> in anhydrous acetonitrile (pyridine as catalyst) to produce the crude target compounds <bold>4a-4c</bold>. The crude compounds were filtered at room temperature and then recrystallized twice from methyl alcohol to give the refined product. The reagents and materials that were used in the syntheses are easily commercially available, and the synthetic route resulted in high atom economy with good utilisation of reactant atoms in the end products.</p><p>The newly synthesised compounds <bold>4a-4c</bold> were then evaluated for inhibition activities against <italic>Sm</italic>ChiB. The results revealed that all three compounds were competitive inhibitors against <italic>Sm</italic>ChiB and showed improved inhibitory activities when compared with that of berberine. The <italic>K</italic><sub>i</sub> values of compound <bold>4a-4c</bold> against <italic>Sm</italic>ChiB were 0.68, 2.36, and 0.15&#x02009;&#x003bc;M, respectively (<xref rid="t0001" ref-type="table">Table 1</xref>, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/14756366.2020.1837123">Figure S1</ext-link>).</p><p>Berberine have been reported to be a broad-spectrum inhibitor of several GH18 chitinases, and therefore the inhibitory activities of compounds <bold>4a-4c</bold> against other GH18 chitinases, including <italic>Of</italic>ChtI, <italic>Hs</italic>Cht, and hAMCase, were also evaluated. As shown in <xref rid="t0001" ref-type="table">Table 1</xref> and <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/14756366.2020.1837123">Figure S2</ext-link>, compounds <bold>4a-4c</bold> exhibited various degree of improvement in inhibitory activities against <italic>Of</italic>ChtI, <italic>Hs</italic>Cht, and hAMCase when compared to berberine. In particular, compound <bold>4c</bold> showed the highest inhibitory activity against all tested GH18 chitinases. The <italic>K</italic><sub>i</sub> values of compound <bold>4c</bold> towards <italic>Of</italic>ChtI, <italic>Hs</italic>Cht, and hAMCase were 3.03, 0.35, and 0.80&#x02009;&#x003bc;M, respectively.</p></sec><sec id="S0003-S2003" disp-level="2"><label>3.3.</label><title>Inhibition mechanism of the compounds</title><p>According to our optimisation strategy, the modification of 9-<italic>O</italic>-position may improve the inhibitory activity of berberine by enhancing its binding affinities towards chitinases. To confirm this hypothesis, <italic>K</italic><sub>d</sub> values were determined using tryptophan fluorescence quenching experiments. As revealed in <xref rid="t0001" ref-type="table">Table 1</xref> and <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/14756366.2020.1837123">Figure S3</ext-link>, berberine binds to <italic>Sm</italic>ChiB with a <italic>K</italic><sub>d</sub> of 11.98&#x02009;&#x003bc;M. The <italic>K</italic><sub>d</sub> values of compounds <bold>4a-4c</bold> against <italic>Sm</italic>ChiB were 1.12, 2.99 and 0.19&#x02009;&#x003bc;M, respectively, showing good agreement with <italic>K</italic><sub>i</sub> values (<xref rid="t0001" ref-type="table">Table 1</xref> and <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/14756366.2020.1837123">Figure S1</ext-link>). The <italic>K</italic><sub>d</sub> values of berberine towards <italic>Of</italic>ChtI, <italic>Hs</italic>Cht and hAMCase were 20.61, 21.89 and 58.03&#x02009;&#x003bc;M, respectively, which were also consistent with the <italic>K</italic><sub>i</sub> values. Compared with berberine, compound <bold>4c</bold> showed a much lower <italic>K</italic><sub>d</sub> against <italic>Of</italic>ChtI, <italic>Hs</italic>Cht and hAMCase with values of 2.58, 0.34 and 1.12&#x02009;&#x003bc;M (<xref rid="t0001" ref-type="table">Table 1</xref>, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/14756366.2020.1837123">Figure S4</ext-link>). These results showed that modification at the 9-<italic>O</italic>-position increased binding affinity.</p><p>To further understand the inhibitory mechanism of compounds <bold>4a-4c</bold>, the structure-based molecular docking was performed to reveal the details responsible for the enhanced binding affinity. The binding modes of <bold>4a-4c</bold> against <italic>Sm</italic>ChiB were nearly identical to that of berberine. The tetracycle moiety of the compounds occupied the substrate-binding cleft from subsites +1 to +2 via &#x003c0;&#x02013;&#x003c0; stacking interactions with Trp<sup>97</sup> and Trp<sup>220</sup>. The 9-<italic>O</italic>-position substituents of the berberine analogues inserted into the extended hydrophobic pocket (<xref ref-type="fig" rid="F0002">Figure 2</xref>). As a result, the berberine analogues were able to form additional interactions such as hydrogen bonds and stacking interactions with surrounding residues of <italic>Sm</italic>ChiB, which may account for their increased inhibitory activities. For example, compound <bold>4a</bold> formed a hydrogen bond with Phe<sup>191</sup> via the carbonyl group of the methyl succinyl substituent. Compound <bold>4&#x02009;b</bold> formed a T-shaped stacking interaction with Phe<sup>190</sup> via its benzene ring. For compound <bold>4c</bold>, the 6-fluoronicotinoyl substituent group formed both hydrogen bond and T-shaped stacking interactions with Phe<sup>191</sup> and Phe<sup>190</sup>, respectively, which may account for its optimal inhibitory activity against <italic>Sm</italic>ChiB.</p><fig id="F0002" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>Modelled complex structures of compounds <bold>4a</bold>-<bold>4c</bold> in <italic>Sm</italic>ChiB. Details of the interaction of compound <bold>4a</bold> (A), <bold>4&#x02009;b</bold> (B) and <bold>4c</bold> (C) with <italic>Sm</italic>ChiB. Compound <bold>4a</bold> is shown in blue, compound <bold>4&#x02009;b</bold> is shown in magenta and compound <bold>4c</bold> is shown in cyan. Residues that participate in binding are shown in yellow. Hydrogen bonds are shown as dashed black lines. The numbers indicate the subsite to which the compounds are bound.</p></caption><graphic content-type="color" xlink:href="IENZ_A_1837123_F0002_C"/></fig><p>As compound <bold>4c</bold> showed the highest inhibitory activity against all GH18 chitinases studied, its binding mechanism towards <italic>Of</italic>ChtI, <italic>Hs</italic>Cht and hAMCase were also studied by molecular docking (<xref ref-type="fig" rid="F0003">Figure 3</xref>). The molecular docking results revealed that compound <bold>4c</bold> inhibited these enzymes via a similar mechanism. Compound <bold>4c</bold> bound in the active pocket across the +1 and +2 subsites of the enzymes. The conjugate tetracycle plane formed &#x003c0;&#x02013;&#x003c0; stacking interactions with conserved tryptophan residues (Trp<sup>107</sup> and Trp<sup>223</sup> in <italic>Of</italic>ChtI, Trp<sup>99</sup> and Trp<sup>218</sup> in <italic>Hs</italic>Cht and hAMCase). The 6-fluoronicotinoyl group inserted into the extended hydrophobic pockets of enzymes that results in hydrogen bonds formation between the nitrogen atom of the heterocyclic aromatic ring and the hydrogen atom of surrounding residues (Gly<sup>187</sup> and Ala<sup>186</sup> in <italic>Hs</italic>Cht and hAMCase). These hydrogen bonds appear to be important for its inhibitory activity, because the <italic>K</italic><sub>i</sub> values of compound <bold>4c</bold> against <italic>Hs</italic>Cht and hAMCase were 54 and 81-fold higher than that of berberine, whereas the failure formation of hydrogen bond of compound <bold>4c</bold> with <italic>Of</italic>ChtI and the inhibitory activity only increased 7.5-fold higher than that of berberine (<xref rid="t0001" ref-type="table">Table 1</xref>, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/14756366.2020.1837123">Figure S2</ext-link>).</p><fig id="F0003" orientation="portrait" position="float"><label>Figure 3.</label><caption><p>Modelled structures of compound <bold>4c</bold> in <italic>Of</italic>ChtI (A), <italic>Hs</italic>Cht (B), and hAMCase (C). Compound <bold>4c</bold> is shown in stick representation with carbon atoms in cyan. Amino acids that interact with compound <bold>4c</bold> are labelled and shown in stick representation with carbon atoms in yellow. Hydrogen bonds are shown as dashed black lines. The numbers indicate the subsite to which compound <bold>4c</bold> is bound.</p></caption><graphic content-type="color" xlink:href="IENZ_A_1837123_F0003_C"/></fig></sec></sec><sec id="S0004" disp-level="1"><label>4.</label><title>Conclusions</title><p>In the current study, we successfully developed a structure-optimisation strategy of berberine to improve the inhibitory activity against GH18 chitinases by taking advantage of an unoccupied hydrophobic cavity of the target enzyme. This work firstly reveals the binding mode of the natural product berberine in GH18 chitinase and provides a new path for exploring berberine-based molecules as promising GH18 chitinase inhibitors.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SM7153"><caption><title>Supplemental Material</title></caption><media xlink:href="IENZ_A_1837123_SM7153.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><title>Acknowledgements</title><p>The authors thank Prof. Yong Zhou (Dalian University of Technology) for the assistance in crystal structure resolving. The authors also thank the staff of BL18U Beamline of National Facility for Protein Science Shanghai at Shanghai Synchrotron Radiation Facility for assistance during data collection.</p></ack><sec id="S0005" disp-level="1" sec-type="COI-statement"><title>Disclosure statement</title><p>All authors declare no competing financial interest.</p></sec><ref-list><title>References</title><ref id="CIT0001"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fuchs</surname><given-names>R</given-names></name>, <name name-style="western"><surname>McPherson</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Drahos</surname><given-names>D.</given-names></name></person-group>
<article-title>Cloning of a <italic>Serratia marcescens</italic> gene encoding chitinase</article-title>. <source>Appl Environ Microbiol</source>
<year>1986</year>;<volume>51</volume>:<fpage>504</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">16347012</pub-id></mixed-citation></ref><ref id="CIT0002"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jones</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Grady</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>Suslow</surname><given-names>TV</given-names></name>, <name name-style="western"><surname>Bedbrook</surname><given-names>JR.</given-names></name></person-group>
<article-title>Isolation and characterization of genes encoding two chitinase enzymes from <italic>Serratia marcescens</italic></article-title>. <source>Embo J</source>
<year>1986</year>;<volume>5</volume>:<fpage>467</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="pmid">16453672</pub-id></mixed-citation></ref><ref id="CIT0003"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Suzuki</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Taiyoji</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sugawara</surname><given-names>N</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>The third chitinase gene (chiC) of <italic>Serratia marcescens</italic> 2170 and the relationship of its product to other bacterial chitinases</article-title>. <source>Biochem J</source>
<year>1999</year>;<volume>343</volume>:<fpage>587</fpage>&#x02013;<lpage>96</lpage>.<pub-id pub-id-type="pmid">10527937</pub-id></mixed-citation></ref><ref id="CIT0004"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vaaje-Kolstad</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Horn</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>S&#x000f8;rlie</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Eijsink</surname><given-names>VG.</given-names></name></person-group>
<article-title>The chitinolytic machinery of <italic>Serratia marcescens-a model system for enzymatic degradation of recalcitrant polysaccharides</italic></article-title>. <source>Febs J</source>
<year>2013</year>;<volume>280</volume>:<fpage>3028</fpage>&#x02013;<lpage>49</lpage>.<pub-id pub-id-type="pmid">23398882</pub-id></mixed-citation></ref><ref id="CIT0005"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Egerton</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Underwood</surname><given-names>AP</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Expression and secretion of a larval-specific chitinase (family 18 glycosyl hydrolase) by the infective stages of the parasitic nematode, Onchocerca volvulus</article-title>. <source>J Biol Chem</source>
<year>2001</year>;<volume>276</volume>:<fpage>42557</fpage>&#x02013;<lpage>64</lpage>.<pub-id pub-id-type="pmid">11535590</pub-id></mixed-citation></ref><ref id="CIT0006"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vinetz</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Dave</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Specht</surname><given-names>CA</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>The chitinase PfCHT1 from the human malaria parasite <italic>Plasmodium falciparum</italic> lacks proenzyme and chitin-binding domains and displays unique substrate preferences</article-title>. <source>Proc Natl Acad Sci USA</source>
<year>1999</year>;<volume>96</volume>:<fpage>14061</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">10570198</pub-id></mixed-citation></ref><ref id="CIT0007"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Genta</surname><given-names>FA</given-names></name>, <name name-style="western"><surname>Blanes</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Cristofoletti</surname><given-names>PT</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Purification, characterization and molecular cloning of the major chitinase from <italic>Tenebrio molitor</italic> larval midgut</article-title>. <source>Insect Biochem Mol Biol</source>
<year>2006</year>;<volume>36</volume>:<fpage>789</fpage>&#x02013;<lpage>800</lpage>.<pub-id pub-id-type="pmid">17027845</pub-id></mixed-citation></ref><ref id="CIT0008"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fukamizo</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kramer</surname><given-names>KJ.</given-names></name></person-group>
<article-title>Mechanism of chitin hydrolysis by the binary chitinase system in insect moulting fluid</article-title>. <source>Insect Biochem</source>
<year>1985</year>;<volume>15</volume>:<fpage>141</fpage>&#x02013;<lpage>5</lpage>.</mixed-citation></ref><ref id="CIT0009"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Homer</surname><given-names>RJ</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation</article-title>. <source>Science</source>
<year>2004</year>;<volume>304</volume>:<fpage>1678</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="pmid">15192232</pub-id></mixed-citation></ref><ref id="CIT0010"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kawada</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hachiya</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Arihiro</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Mizoguchi</surname><given-names>E.</given-names></name></person-group>
<article-title>Role of mammalian chitinases in inflammatory conditions</article-title>. <source>Keio J Med</source>
<year>2007</year>;<volume>56</volume>:<fpage>21</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">17392594</pub-id></mixed-citation></ref><ref id="CIT0011"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wiesner</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Specht</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>CK</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Chitin recognition via chitotriosidase promotes pathologic type-2 helper T cell responses to cryptococcal infection</article-title>. <source>PLoS Pathog</source>
<year>2015</year>;<volume>11</volume>:<fpage>e1004701</fpage>.<pub-id pub-id-type="pmid">25764512</pub-id></mixed-citation></ref><ref id="CIT0012"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>LK</given-names></name>, <name name-style="western"><surname>Morita</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Kobayashi</surname><given-names>Y</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>AMCase is a crucial regulator of type 2 immune responses to inhaled house dust mites</article-title>. <source>Proc Natl Acad Sci U S A</source>
<year>2015</year>;<volume>112</volume>:<fpage>E2891</fpage>&#x02013;<lpage>E9</lpage>.<pub-id pub-id-type="pmid">26038565</pub-id></mixed-citation></ref><ref id="CIT0013"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Berdy</surname><given-names>J.</given-names></name></person-group>
<article-title>Bioactive microbial metabolites</article-title>. <source>J Antibiot</source>
<year>2005</year>;<volume>58</volume>:<fpage>1</fpage>&#x02013;<lpage>26</lpage>.</mixed-citation></ref><ref id="CIT0014"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Katz</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Baltz</surname><given-names>RH.</given-names></name></person-group>
<article-title>Natural product discovery: past, present, and future</article-title>. <source>J Ind Microbiol Biotechnol</source>
<year>2016</year>;<volume>43</volume>:<fpage>155</fpage>&#x02013;<lpage>76</lpage>.<pub-id pub-id-type="pmid">26739136</pub-id></mixed-citation></ref><ref id="CIT0015"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koehn</surname><given-names>FE</given-names></name>, <name name-style="western"><surname>Carter</surname><given-names>GT.</given-names></name></person-group>
<article-title>The evolving role of natural products in drug discovery</article-title>. <source>Nat Rev Drug Discov</source>
<year>2005</year>;<volume>4</volume>:<fpage>206</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="pmid">15729362</pub-id></mixed-citation></ref><ref id="CIT0016"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sakuda</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Isogai</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Matsumoto</surname><given-names>S</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>The structure of allosamidin, a novel insect chitinase inhibitor, produced by <italic>Streptomyces sp</italic></article-title>. <source>Tetrahedron Lett</source>
<year>1986</year>;<volume>27</volume>:<fpage>2475</fpage>&#x02013;<lpage>8</lpage>.</mixed-citation></ref><ref id="CIT0017"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shiomi</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Arai</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Iwai</surname><given-names>Y</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Structure of argifin, a new chitinase inhibitor produced by <italic>Gliocladium sp</italic></article-title>. <source>Tetrahedron Lett</source>
<year>2000</year>;<volume>41</volume>:<fpage>2141</fpage>&#x02013;<lpage>3</lpage>.</mixed-citation></ref><ref id="CIT0018"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arai</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Shiomi</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Yamaguchi</surname><given-names>Y</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Argadin, a new chitinase inhibitor, produced by <italic>Clonostachys sp</italic>. FO-7314</article-title>. <source>Chem Pharm Bull (Tokyo)</source>
<year>2000</year>;<volume>48</volume>:<fpage>1442</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">11045447</pub-id></mixed-citation></ref><ref id="CIT0019"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tabudravu</surname><given-names>JN</given-names></name>, <name name-style="western"><surname>Eijsink</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Gooday</surname><given-names>G</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Psammaplin A, a chitinase inhibitor isolated from the Fijian marine sponge <italic>Aplysinella rhax</italic></article-title>. <source>Bioorg Med Chem</source>
<year>2002</year>;<volume>10</volume>:<fpage>1123</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">11836123</pub-id></mixed-citation></ref><ref id="CIT0020"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kato</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Shizuri</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Izumida</surname><given-names>H</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Styloguanidines, new chitinase inhibitors from the marine sponge <italic>Stylotella aurantium</italic></article-title>. <source>Tetrahedron Lett</source>
<year>1995</year>;<volume>36</volume>:<fpage>2133</fpage>&#x02013;<lpage>6</lpage>.</mixed-citation></ref><ref id="CIT0021"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Duan</surname><given-names>Y</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Microbial secondary metabolite, phlegmacin B<sub>1</sub>, as a novel inhibitor of insect chitinolytic enzymes</article-title>. <source>J Agric Food Chem</source>
<year>2017</year>;<volume>65</volume>:<fpage>3851</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">28457127</pub-id></mixed-citation></ref><ref id="CIT0022"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Houston</surname><given-names>DR</given-names></name>, <name name-style="western"><surname>Eggleston</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Synstad</surname><given-names>B</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>The cyclic dipeptide CI-4 [cyclo-(L-Arg-D-Pro)] inhibits family 18 chitinases by structural mimicry of a reaction intermediate</article-title>. <source>Biochem J</source>
<year>2002</year>;<volume>368</volume>:<fpage>23</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">12323074</pub-id></mixed-citation></ref><ref id="CIT0023"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rao</surname><given-names>FV</given-names></name>, <name name-style="western"><surname>Andersen</surname><given-names>OA</given-names></name>, <name name-style="western"><surname>Vora</surname><given-names>KA</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Methylxanthine drugs are chitinase inhibitors: investigation of inhibition and binding modes</article-title>. <source>Chem Biol</source>
<year>2005</year>;<volume>12</volume>:<fpage>973</fpage>&#x02013;<lpage>80</lpage>.<pub-id pub-id-type="pmid">16183021</pub-id></mixed-citation></ref><ref id="CIT0024"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vuddanda</surname><given-names>PR</given-names></name>, <name name-style="western"><surname>Chakraborty</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Singh</surname><given-names>S.</given-names></name></person-group>
<article-title>Berberine: a potential phytochemical with multispectrum therapeutic activities</article-title> . <source>Expert Opin Investig Drugs</source>
<year>2010</year>;<volume>19</volume>:<fpage>1297</fpage>&#x02013;<lpage>307</lpage>.</mixed-citation></ref><ref id="CIT0025"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>IP</given-names></name>, <name name-style="western"><surname>Mahajan</surname><given-names>S.</given-names></name></person-group>
<article-title>Berberine and its derivatives: a patent review (2009 - 2012)</article-title>. <source>Expert Opin Ther Pat</source>
<year>2013</year>;<volume>23</volume>:<fpage>215</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="pmid">23231038</pub-id></mixed-citation></ref><ref id="CIT0026"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Xun</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name></person-group>
<article-title>A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs</article-title>. <source>Anticancer Drugs</source>
<year>2009</year>;<volume>20</volume>:<fpage>757</fpage>&#x02013;<lpage>69</lpage>.<pub-id pub-id-type="pmid">19704371</pub-id></mixed-citation></ref><ref id="CIT0027"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>H-L</given-names></name>, <name name-style="western"><surname>Sui</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Qiao</surname><given-names>C-F</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Sustained antidiabetic effects of a berberine-containing Chinese herbal medicine through regulation of hepatic gene expression</article-title>. <source>Diabetes</source>
<year>2012</year>;<volume>61</volume>:<fpage>933</fpage>&#x02013;<lpage>43</lpage>.<pub-id pub-id-type="pmid">22396199</pub-id></mixed-citation></ref><ref id="CIT0028"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peng</surname><given-names>W-H</given-names></name>, <name name-style="western"><surname>Lo</surname><given-names>K-L</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>Y-H</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Berberine produces antidepressant-like effects in the forced swim test and in the tail suspension test in mice</article-title>. <source>Life Sci</source>
<year>2007</year>;<volume>81</volume>:<fpage>933</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">17804020</pub-id></mixed-citation></ref><ref id="CIT0029"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fatehi-Hassanabad</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Jafarzadeh</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Tarhini</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Fatehi</surname><given-names>M.</given-names></name></person-group>
<article-title>The antihypertensive and vasodilator effects of aqueous extract from <italic>Berberis vulgaris</italic> fruit on hypertensive rats</article-title>. <source>Phytother Res</source>
<year>2005</year>;<volume>19</volume>:<fpage>222</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="pmid">15934023</pub-id></mixed-citation></ref><ref id="CIT0030"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>da Silva</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>de Andrade Neto</surname><given-names>JB</given-names></name>, <name name-style="western"><surname>da Silva</surname><given-names>CR</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Berberine antifungal activity in fluconazole-resistant pathogenic yeasts: action mechanism evaluated by flow cytometry and biofilm growth inhibition in <italic>Candida</italic> spp</article-title>. <source>Antimicrob Agents Chemother</source>
<year>2016</year>;<volume>60</volume>:<fpage>3551</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">27021328</pub-id></mixed-citation></ref><ref id="CIT0031"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miyazawa</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Fujioka</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ishikawa</surname><given-names>Y.</given-names></name></person-group>
<article-title>Insecticidal compounds from <italic>Phellodendron amurense</italic> active against <italic>Drosophila melanogaster</italic></article-title>. <source>J Sci Food Agric</source>
<year>2002</year>;<volume>82</volume>:<fpage>830</fpage>&#x02013;<lpage>3</lpage>.</mixed-citation></ref><ref id="CIT0032"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Iwasa</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Moriyasu</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Nader</surname><given-names>B.</given-names></name></person-group>
<article-title>Fungicidal and herbicidal activities of berberine related alkaloids</article-title>. <source>Biosci Biotechnol Biochem</source>
<year>2000</year>;<volume>64</volume>:<fpage>1998</fpage>&#x02013;<lpage>2000</lpage>.<pub-id pub-id-type="pmid">11055412</pub-id></mixed-citation></ref><ref id="CIT0033"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duan</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Glycoside hydrolase family 18 and 20 enzymes are novel targets of the traditional medicine berberine</article-title>. <source>J Biol Chem</source>
<year>2018</year>;<volume>293</volume>:<fpage>15429</fpage>&#x02013;<lpage>38</lpage>.<pub-id pub-id-type="pmid">30135205</pub-id></mixed-citation></ref><ref id="CIT0034"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Qu</surname><given-names>M</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Fully deacetylated chitooligosaccharides act as efficient glycoside hydrolase family 18 chitinase inhibitors</article-title>. <source>J Biol Chem</source>
<year>2014</year>;<volume>289</volume>:<fpage>17932</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="pmid">24828498</pub-id></mixed-citation></ref><ref id="CIT0035"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lehrer</surname><given-names>S.</given-names></name></person-group>
<article-title>Solute perturbation of protein fluorescence. The quenching of the tryptophyl fluorescence of model compounds and of lysozyme by iodide ion</article-title>. <source>Biochemistry</source>
<year>1971</year>;<volume>10</volume>:<fpage>3254</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="pmid">5119250</pub-id></mixed-citation></ref><ref id="CIT0036"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Samworth</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Degli</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Lenaz</surname><given-names>G.</given-names></name></person-group>
<article-title>Quenching of the intrinsic tryptophan fluorescence of mitochondrial ubiquinol-cytochrome-c reductase by the binding of ubiquinone</article-title>. <source>Eur J Biochem</source>
<year>1988</year>;<volume>171</volume>:<fpage>81</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">2828059</pub-id></mixed-citation></ref><ref id="CIT0037"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McCoy</surname><given-names>AJ.</given-names></name></person-group>
<article-title>Solving structures of protein complexes by molecular replacement with Phaser</article-title>. <source>Acta Crystallogr D Biol Crystallogr</source>
<year>2007</year>;<volume>63</volume>:<fpage>32</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="pmid">17164524</pub-id></mixed-citation></ref><ref id="CIT0038"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adams</surname><given-names>PD</given-names></name>, <name name-style="western"><surname>Afonine</surname><given-names>PV</given-names></name>, <name name-style="western"><surname>Bunk&#x000f3;czi</surname><given-names>G</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>PHENIX: a comprehensive Python-based system for macromolecular structure solution</article-title>. <source>Acta Crystallogr D Biol Crystallogr</source>
<year>2010</year>;<volume>66</volume>:<fpage>213</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="pmid">20124702</pub-id></mixed-citation></ref><ref id="CIT0039"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Emsley</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Lohkamp</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Scott</surname><given-names>WG</given-names></name>, <name name-style="western"><surname>Cowtan</surname><given-names>K.</given-names></name></person-group>
<article-title>Features and development of Coot</article-title>. <source>Acta Crystallogr D Biol Crystallogr</source>
<year>2010</year>;<volume>66</volume>:<fpage>486</fpage>&#x02013;<lpage>501</lpage>.<pub-id pub-id-type="pmid">20383002</pub-id></mixed-citation></ref><ref id="CIT0040"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Laskowski</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>MacArthur</surname><given-names>MW</given-names></name>, <name name-style="western"><surname>Moss</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>Thornton</surname><given-names>JM.</given-names></name></person-group>
<article-title>Procheck-a program to check the stereochemical quality of protein structures</article-title>. <source>J Appl Crystallogr</source>
<year>1993</year>;<volume>26</volume>:<fpage>283</fpage>&#x02013;<lpage>91</lpage>.</mixed-citation></ref><ref id="CIT0041"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sch&#x000fc;ttelkopf</surname><given-names>AW</given-names></name>, <name name-style="western"><surname>Van Aalten</surname><given-names>DM.</given-names></name></person-group>
<article-title>PRODRG: a tool for high-throughput crystallography of protein-ligand complexes</article-title>. <source>Acta Crystallogr D Biol Crystallogr</source>
<year>2004</year>;<volume>60</volume>:<fpage>1355</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="pmid">15272157</pub-id></mixed-citation></ref><ref id="CIT0042"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morris</surname><given-names>GM</given-names></name>, <name name-style="western"><surname>Huey</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Lindstrom</surname><given-names>W</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility</article-title>. <source>J Comput Chem</source>
<year>2009</year>;<volume>30</volume>:<fpage>2785</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="pmid">19399780</pub-id></mixed-citation></ref><ref id="CIT0043"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Davies</surname><given-names>GJ</given-names></name>, <name name-style="western"><surname>Wilson</surname><given-names>KS</given-names></name>, <name name-style="western"><surname>Henrissat</surname><given-names>B.</given-names></name></person-group>
<article-title>Nomenclature for sugar-binding subsites in glycosyl hydrolases</article-title>. <source>Biochem J</source>
<year>1997</year>;<volume>321</volume>:<fpage>557</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">9020895</pub-id></mixed-citation></ref><ref id="CIT0044"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lo</surname><given-names>C-Y</given-names></name>, <name name-style="western"><surname>Hsu</surname><given-names>L-C</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>M-S</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Synthesis and anticancer activity of a novel series of 9-<italic>O</italic>-substituted berberine derivatives: a lipophilic substitute role</article-title>. <source>Bioorg Med Chem Lett</source>
<year>2013</year>;<volume>23</volume>:<fpage>305</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">23182088</pub-id></mixed-citation></ref><ref id="CIT0045"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bodiwala</surname><given-names>HS</given-names></name>, <name name-style="western"><surname>Sabde</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Mitra</surname><given-names>D</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Synthesis of 9-substituted derivatives of berberine as anti-HIV agents</article-title>. <source>Eur J Med Chem</source>
<year>2011</year>;<volume>46</volume>:<fpage>1045</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">21295891</pub-id></mixed-citation></ref><ref id="CIT0046"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>M-Y</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>Z-J</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Design, synthesis and anti-inflammatory effects of novel 9-<italic>O</italic>-substituted-berberine derivatives</article-title>. <source>MedChemComm</source>
<year>2016</year>;<volume>7</volume>:<fpage>658</fpage>&#x02013;<lpage>66</lpage>.</mixed-citation></ref><ref id="CIT0047"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Delgado-Cam&#x000f3;n</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Jarne</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Cebolla</surname><given-names>VL</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<article-title>Resonance driven regioselective demethylation of berberine. Microwave assisted synthesis of berberrubine and its assessment as fluorescent chemosensor for alkanes</article-title>. <source>Tetrahedron</source>
<year>2015</year>;<volume>71</volume>:<fpage>6148</fpage>&#x02013;<lpage>54</lpage>.</mixed-citation></ref></ref-list></back></article>